Not only has elevated TWIST1 been associated with poorer survival in several cancers, including head and neck, but TWIST1 protein attenuates the response to chemotherapeutic drugs, which provides a rationale for the worse clinical outcomes in high TWIST1 expression patients (47, 55). This evidence concerns the gene TWIST1 and cancer.